↓ Skip to main content

PLOS

Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor

Overview of attention for article published in PLOS ONE, February 2011
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Readers on

mendeley
29 Mendeley
citeulike
1 CiteULike
Title
Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor
Published in
PLOS ONE, February 2011
DOI 10.1371/journal.pone.0016975
Pubmed ID
Authors

Yanlai Lai, Mei Qiao, Meihua Song, Susan T. Weintraub, Yuzuru Shiio

Abstract

The von Hippel-Lindau (VHL) tumor suppressor gene encodes a component of a ubiquitin ligase complex, which is best understood as a negative regulator of hypoxia inducible factor (HIF). VHL ubiquitinates and degrades the α subunits of HIF, and this is proposed to suppress tumorigenesis and tumor angiogenesis. However, several lines of evidence suggest that there are unidentified substrates or targets for VHL that play important roles in tumor suppression.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 7%
France 1 3%
Unknown 26 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 24%
Student > Doctoral Student 5 17%
Student > Ph. D. Student 5 17%
Professor > Associate Professor 3 10%
Student > Master 2 7%
Other 2 7%
Unknown 5 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 34%
Biochemistry, Genetics and Molecular Biology 8 28%
Medicine and Dentistry 2 7%
Business, Management and Accounting 1 3%
Unspecified 1 3%
Other 2 7%
Unknown 5 17%